O‐linked β‐N‐acetylglucosamine (O‐<scp>GlcNAc</scp>) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy
Bingxue Qi(People 's Hospital of Jilin Province), Li Kang(Case Western Reserve University)
Cited by 19
Related Papers
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes
|Clinical Kidney Journal|2024|2
CHRONIC ETHANOL FEEDING DISRUPTS BOTH LIPID AND GLUCOSE HOMEOSTASIS IN RAT ADIPOSE TISSUE
|OhioLink ETD Center (Ohio Library and Information Network)|2007|0